Louisiana Attorney General James “Buddy” Caldwell is going after pharmaceutical companies for alleged consumer fraud. Caldwell appointed nine private law firms along with 17 private antitrust attorneys working for those firms to work on behalf of the state.
The AG’s office accuses AstraZeneca of violating anti-trust laws by delaying the introduction of a generic version of Toprol-XL, a drug that treats chest pain and high blood pressure.
“Because of the enormity of the project, the state has retained the services of multiple law firms, some of whom have worked with the state previously and have a proven track record of success, some of whom are experts in this particular field of antitrust litigation and all of whom are excellent and experienced trial attorneys,” Caldwell’s spokesman Aaron Sadler said.
Caldwell has long been under fire for hiring outside private law firms for civil cases brought on behalf of the state by the Louisiana Attorney General’s Office.
Full content: The Louisiana Record
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI